||EPS - Basic
||Market Cap (m)
|Equity Investment Instruments
Braveheart Investment Share Discussion Threads
Showing 126 to 150 of 150 messages
|bf, it does appear a few have latched on to it and not that unexpected taking into account the progress over recent months,...GL S|
|Hi Swizz the above article certainly highlights the potential here.
I had topped up a couple of times and was hoping to quietly carry on but all of a sudden today somebody else has cottoned on to it and blimey the price jumped. Not sure if it got a tip somewhere but wouldn't be surprised.
I'll give it a week or two to settle down then carry on slowly building.
|bf, welcome aboard and good to have another poster, unfortunately TB is not at his best during media interviews, which is in complete contrast when he is one to one, the turn around since TB took the reigns is seriously impressive and bodes well for the future, there is some great things happening at Kirkstall, Paraytec, DI4D, Pyreos, Gyrometric, Viking, Vascular Flow, with the added bonus that everyone of them is producing and generating revenue, .....GL S
Braveheart Investment keeping the momentum going
INVESTMENT OVERVIEW: BRH THE BIG PICTURE
Braveheart seeks to back nascent technology companies and work closely with their boards
It is hard sometimes to value an investment company like Braveheart Investment Group PLC (LON:BRH), which plays the long game, backing promising technology businesses.
Then, along comes a “value realisation” moment, as they call it in the trade, and things get a bit clearer.
Such was the case in July, when the company announced it was in advanced talks to dispose of a stake in one of its investee companies, mLED Limited.
The share price doubled, and though it came off the boil after the sales was confirmed in September, the shares are still up a very handy 77% over the last year.
The group has a 1.25% direct holding and 3.75% stake held through subsidiary Strathclyde Investment Fund in mLED.
Proceeds from the sale were £399,000 in cash compared to a book value of £96,000.
The money went in the kitty, to invest in more promising technology companies.
Talking of which … shares were on the rise again in January 2017 as the company took a 47% stake in Gyrometric Systems Limited, an engineering firm using technology developed at Nottingham Trent University.
Gyrometric provides monitoring technology that measures the performance of drive shafts in a wide variety of applications.
In effect, the technology tunes the devices, enabling them to operate at maximum efficiency, thereby saving energy, maintenance and capital costs.
The large stake taken by Braveheart represents a continuation of the change of strategy by Braveheart, with the company gaining in confidence and backing its judgement more heavily.
Not that Gyrometric seems like a particularly risky investment. Braveheart said Gyrometric already has established sales partners in Germany and Asia on which it will now build and expects to break-even in 2017.
Selling a stake in a company provides a nice occasional bonus for the company, but the steady income is provided by its wholly-owned subsidiary, Viking Fund Managers.
Viking's main fund management income comes from the Finance Yorkshire Equity Fund contract, but it also provides specialist fund management services to other funds that are in 'run-out' mode.
This specialised management work tends to generate enhanced fees in excess of standard fund management fees due to the intensive nature of this work.
The emphasis for the FYEF is now on portfolio management rather than in seeking new investments and the unit is seeking to win the management contracts for further funds.
Viking was recently awarded an additional sum of £2 million of new capital to invest through the existing FYED contract, which means that the investment phase of this contract has been extended into 2017 – March, to be precise.
Once this extended investment phase of the contract is completed, Viking will concentrate on realising fund investments with this part of the management contract expected to be completed during 2019.
Viking was not successful in winning a fund management contract for the initial phase of the new Northern Powerhouse Investment Fund initiative; however it continues to work with a number of third parties with a view to gaining new fund management contracts.
Interim results for the whole group released in October revealed costs were cut in half from a year earlier, which meant pre-tax profits for the six months to September 30 of £475,000 were the largest since the company floated more than eight years ago.
They were achieved on revenues of £562,000 and compared with a loss in the comparable period last year of just over £1mln.
Overheads fell from £868,000 to £435,000.
The comp recently took on 33% of Paraytec, a York-based scientific instruments specialist, and 28% of Kirkstall, which makes equipment for cell tissue labs.
Both companies are performing well, either meeting or exceeding internal targets set for them.
Sales have now begun of Paraytec's ActiPix D200 system, which was recently introduced into the global pharmaceutical market, Braveheart revealed.
Sirius Analytical, one of the first ActiPix licensees, has successfully launched a new drug dissolution imager, incorporating ActiPix technology. It has already met with strong interest from global research laboratories that are interested in licensing the ActiPix wizardry, Braveheart said.
The royalties generated from such licences are expected to comprise the majority of Paraytec's future income.
Meanwhile, sales of Kirkstall’s 'organ-on-a-chip` system, Quasi Vivo, are ahead of forecast.
Research group Research and Markets estimates that the global `organ-on-a-chip` market is poised to grow at a compound annual growth rate of around 69% over the next decade to reach about US$6.13 billion by 2025.|
|Very quiet here considering the potential highlighted today. Bought a few as it appears they may have a decent future with one or more of their stake holdings.
Making cash and cutting overheads, cant argue with that and a Mcap under £4M.
Todays interview isn't the most flowing and I think this guy would struggle to explain how to boil an egg but the last few sentences of what he says are worth hearing.
|The Strategic portfolio would appear to be taking its next meaningful step, an intriguing development and I wonder what the Braveheart team have spotted?
The mind boggles in relation to the remote monitoring applications and all things IOT,.....GL S
|Why is Braveheart so quiet?,there is considerable material news flow from their investee companies and not a word, very odd,....GL S
Finance Yorkshire secure another £5M extension.
Kirkstall Ltd sign a marketing and distribution agreement with Lonza! Campaign starts in 2017.
Pyreos raise another £1.8M to leverage their sensor tech into multi billion wearable technology sector.
The list of recent news continues, with Paraytec, Concepta, Vascular flow, etc.!!|
|Viking 1 of 5 chosen to support £400M equity element of NIPF,....GL S
The price was 7p when insider trading started, share price is doubled to what it was on Thursday close.
It's up nearly £2m on Mcap for a 381K business sale.|
The price was 7p when insider trading started, share price is doubled to what it was on Thursday|
|Silly reaction to a very profitable sale. Expectations too high it would seem|
|told you all this morning!|
|back down to 14p|
|LND MOVING UP VERY FAST GUYS!!!|
|GWMO starting to moveIt's bubblingGet in before the crowds|
|Run out of steam again. Good Luck all.|
|BIT OF A SHAKE BACK DOWN TO 13- 15|
|GET INTO IRR!!!!! GOT TO BE VERY QUICK!!!|
|INTO THE 20S|
|WILL MOVE ON EVERY TRADE|
|GOING BACK UP AGAIN|
|Almost on the button falia.|
|RIGHT HERE WE GO AGAIN|
|GET READY SHAKE ALMOST OVER|
|WELL 20P ALREADY, I THINK WE WILL DROP BACK TO 15P AND HAVE ANOTHER RISE TO ATLEAST 30P TODAY AND POSSIBLY 50P MONDAY|
|my 30k investment @ 11.30p looking good|